News from NORD

NORD Announces Recipients of 2017 Rare Impact Awards


 

Honorees at NORD’s 2017 Rare Impact Awards will include three clinicians and researchers with expertise in rare diseases. They are Robert Desnick, MD, PhD, of Mount Sinai Hospital and the Icahn School of Medicine in New York City; Frederick Kaplan, MD, of the Perelman School of Medicine at the University of Pennsylvania; and Cynthia Tifft, MD, PhD, of the National Institutes of Health. The three, along with other honorees, will be recognized for their work to improve the lives of patients affected by rare diseases.

The annual charity event will take place this year on May 18 at the Ronald Reagan Building and International Trade Center Amphitheatre in Washington DC. The event is open to the public and is a fundraiser to support NORD programs and services for all individuals who have rare diseases.

Recommended Reading

APS Type 1 Symposium Is Planned
MDedge Hematology and Oncology
Foundation for Prader-Willi Research Highlights Study of Genetic Therapy for Prader-Willi Syndrome
MDedge Hematology and Oncology
Guidelines tackle long-term screening, management of myeloma
MDedge Hematology and Oncology
GAO to launch investigation of FDA’s Orphan Drug program
MDedge Hematology and Oncology
NORD Awards Grants for Rare Disease Research
MDedge Hematology and Oncology
NORD Publishes Basic Principles for Health Coverage Reform
MDedge Hematology and Oncology
NORD Submits Letter to Congress on Pre-Existing Conditions
MDedge Hematology and Oncology
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
MDedge Hematology and Oncology
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
MDedge Hematology and Oncology
Safety of N9-GP for hemophilia B needs further study, FDA committee agrees
MDedge Hematology and Oncology